IMR Press / EJGO / Volume 20 / Issue 4 / pii/1999168

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Case Report

Malignant rhabdoid tumor of the vulva

Show Less
1 Rogaland Central Hospital Gynaecology Dept., Stavanger, Norway
2 Regional Hospital, Gynaecology Dept., Trondheim, Norway
3 Marslifield Clinic (Pathology), Marslifield, WI, USA
4 Sinai Hospital, Division ofGyne-Onco/ogy, Baltimore, Maryland, USA
5 Dartmouth Medical School&Dartmouth-Hitchcock Med. Ctr., Lebanon, NH, USA
Eur. J. Gynaecol. Oncol. 1999, 20(4), 258–261;
Published: 10 August 1999

The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.

Malignant rhabdoid tumor
Back to top